doi:10.16150/j.1671-2870.2021.02.019

Abstract

CLC Number:

R733

References 34

[1]	Zeidan AM, Shallis RM, Wang R, et al. Epidemiology of myelodysplastic syndromes: why characterizing the beast is a prerequisite to taming it[J]. Blood Rev, 2019, 34:1-15. doi: S0268-960X(18)30065-1 pmid: 30314642
[2]	Zeidan AM, Shallis RM, Wang R, et al. Epidemiology of myelodysplastic syndromes: Why characterizing the beast is a prerequisite to taming it[J]. Blood Rev, 2019, 34:1-15. doi: S0268-960X(18)30065-1 pmid: 30314642
[3]	中华医学会血液学分会. 骨髓增生异常综合征中国诊断与治疗指南(2019年版)[J]. 中华血液学杂志, 2019, 40(2):89-97.
[4]	Sakaguchi S, Sakaguchi N, Asano M, et al. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases[J]. J Immunol, 1995, 155(3):1151-1164. pmid: 7636184
[5]	Kanamori M, Nakatsukasa H, Okada M, et al. Induced regulatory T cells: their development, stability, and applications[J]. Trends Immunol, 2016, 37(11):803-811. doi: 10.1016/j.it.2016.08.012 URL
[6]	Rueda CM, Jackson CM, Chougnet CA. Regulatory T-cell-mediated suppression of conventional T-cells and dendritic cells by different cAMP intracellular pathways[J]. Front Immunol, 2016, 7:216.
[7]	Ovcinnikovs V, Ross EM, Petersone L, et al. CTLA-4-mediated transendocytosis of costimulatory molecules primarily targets migratory dendritic cells[J]. Sci Immunol, 2019, 4(35):eaaw0902. doi: 10.1126/sciimmunol.aaw0902 URL
[8]	Gill H, Leung AY, Kwong YL. Molecular and cellular mechanisms of myelodysplastic syndrome: implications on targeted therapy[J]. Int J Mol Sci, 2016, 17(4):440. doi: 10.3390/ijms17040440 URL
[9]	Korn C, Méndez-Ferrer S. Myeloid malignancies and the microenvironment[J]. Blood, 2017, 129(7):811-822. doi: 10.1182/blood-2016-09-670224 URL
[10]	Ruggiero G, Sica M, Luciano L, et al. A case of myelodysplastic syndrome associated with CD14(+)CD56(+) monocytosis, expansion of NK lymphocytes and defect of HLA-E expression[J]. Leuk Res, 2009, 33(1):181-185. doi: 10.1016/j.leukres.2008.03.019 URL
[11]	Landman S, Cruijsen M, Urbano PCM, et al. DNA methyltransferase inhibition promotes Th1 polarization in human CD4⁺ CD25 high FOXP3⁺ regulatory T cells but does not affect their suppressive capacity[J]. J Immunol Res, 2018, 2018:4973964.
[12]	Leone P, Solimando AG, Malerba E, et al. Actors on the scene: immune cells in the myeloma niche[J]. Front Oncol, 2020, 10:599098. doi: 10.3389/fonc.2020.599098 URL
[13]	Mailloux AW, Sugimori C, Komrokji RS, et al. Expansion of effector memory regulatory T cells represents a novel prognostic factor in lower risk myelodysplastic syndrome[J]. J Immunol, 2012, 189(6):3198-208. doi: 10.4049/jimmunol.1200602 pmid: 22875800
[14]	Costantini B, Kordasti SY, Kulasekararaj AG, et al. The effects of 5-azacytidine on the function and number of regulatory T cells and T-effectors in myelodysplastic syndrome[J]. Haematologica, 2013, 98(8):1196-1205. doi: 10.3324/haematol.2012.074823 pmid: 23242597
[15]	Nishikawa H, Jäger E, Ritter G, et al. CD4⁺ CD25⁺ regulatory T cells control the induction of antigen-specific CD4⁺ helper T cell responses in cancer patients[J]. Blood, 2005, 106(3):1008-1011.
[16]	Shi X, Zheng Y, Xu L, et al. The inflammatory cytokine profile of myelodysplastic syndromes: a meta-analysis[J]. Medicine (Baltimore), 2019, 98(22):e15844. doi: 10.1097/MD.0000000000015844 URL
[17]	Zou L, Barnett B, Safah H, et al. Bone marrow is a reservoir for CD4⁺CD25⁺ regulatory T cells that traffic through CXCL12/CXCR4 signals[J]. Cancer Res, 2004, 64(22):8451-8455. doi: 10.1158/0008-5472.CAN-04-1987 URL
[18]	Fritsch RD, Shen X, Illei GG, et al. Abnormal differentia-tion of memory T cells in systemic lupus erythematosus[J]. Arthritis Rheum, 2006, 54(7):2184-2197. doi: 10.1002/art.21943 URL
[19]	Kordasti SY, Ingram W, Hayden J, et al. CD4⁺CD25^high Foxp3⁺ regulatory T cells in myelodysplastic syndrome (MDS)[J]. Blood, 2007, 110(3):847-850. doi: 10.1182/blood-2007-01-067546 pmid: 17412885
[20]	Bleul CC, Wu L, Hoxie JA, et al. The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes[J]. Proc Natl Acad Sci USA, 1997, 94(5):1925-1930. doi: 10.1073/pnas.94.5.1925 URL
[21]	Fragale A, Gabriele L, Stellacci E, et al. IFN regulatory factor-1 negatively regulates CD4⁺ CD25⁺ regulatory T cell differentiation by repressing Foxp3 expression[J]. J Immunol, 2008, 181(3):1673-1682. doi: 10.4049/jimmunol.181.3.1673 URL
[22]	Pinheiro RF, Metze K, Silva MR, et al. The ambiguous role of interferon regulatory factor-1(IRF-1) immunoexpression in myelodysplastic syndrome[J]. Leuk Res, 2009, 33(10):1308-1312. doi: 10.1016/j.leukres.2009.03.008 URL
[23]	Shastri A, Will B, Steidl U, et al. Stem and progenitor cell alterations in myelodysplastic syndromes[J]. Blood, 2017, 129(12):1586-1594. doi: 10.1182/blood-2016-10-696062 pmid: 28159737
[24]	Wolf Y, Anderson AC, Kuchroo VK. TIM3 comes of age as an inhibitory receptor[J]. Nat Rev Immunol, 2020, 20(3):173-185.
[25]	邓圆圆, 范益民. TIM-3在肿瘤免疫中的研究进展[J]. 中华神经创伤外科电子杂志, 2016, 2(2):112-115.
[26]	Sun L, Fu J, Zhou Y. Metabolism controls the balance of Th17/T-regulatory cells[J]. Front Immunol, 2017, 8:1632. doi: 10.3389/fimmu.2017.01632 URL
[27]	Sałkowska A, Karaś K, Karwaciak I, et al. Identification of novel molecular markers of human Th17 cells[J]. Cells, 2020, 9(7):1611. doi: 10.3390/cells9071611 URL
[28]	Bhaskaran N, Faddoul F, Paes da Silva A, et al. IL-1β-myD88-mTOR axis promotes immune-protective IL-17A⁺ Foxp3⁺ cells during mucosal infection and is dysregula-ted with aging[J]. Front Immunol, 2020, 11:595936. doi: 10.3389/fimmu.2020.595936 URL
[29]	Pawlik A, Anisiewicz A, Filip-Psurska B, et al. Divergent effect of tacalcitol (PRI-2191) on Th17 cells in 4T1 tumor bearing young and old ovariectomized mice[J]. Aging Dis, 2020, 11(2):241-253. doi: 10.14336/AD.2019.0618
[30]	Knochelmann HM, Dwyer CJ, Bailey SR, et al. When worlds collide: Th17 and Treg cells in cancer and autoimmunity[J]. Cell Mol Immunol, 2018, 15(5):458-469. doi: 10.1038/s41423-018-0004-4 pmid: 29563615
[31]	Prabhala RH, Pelluru D, Fulciniti M, et al. Elevated IL-17 produced by TH17 cells promotes myeloma cell growth and inhibits immune function in multiple myeloma[J]. Blood, 2010, 115(26):5385-5392. doi: 10.1182/blood-2009-10-246660 pmid: 20395418
[32]	Kahn JD, Chamuleau ME, Westers TM, et al. Regulatory T cells and progenitor B cells are independent prognostic predictors in lower risk myelodysplastic syndromes[J]. Haematologica, 2015, 100(6):e220-e222. doi: 10.3324/haematol.2014.116657 URL
[33]	Williamson BT, Foltz L, Leitch HA. Leitch. Autoimmune syndromes presenting as a paraneoplastic manifestation of myelodysplastic syndromes: clinical features, course, treatment and outcome hematol rep[J]. Hematol Rep, 2016, 8(2):6480. doi: 10.4081/hr.2016.6480 URL
[34]	Moon HW, Kim BH, Park CM, et al. CD4⁺CD25^high Foxp3⁺ regulatory T-cells in hematologic diseases[J]. Korean J Lab Med, 2011, 31(4):231-237.

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References 34

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	FENG Guowei, ZHANG Xiaojuan, GUO Rui, GUAN Zhe, WANG Yue. The prognostic value of pretreatment ¹⁸F-FDG PET/CT in extranodal natural killer/T-cell lymphoma [J]. Journal of Diagnostics Concepts & Practice, 2021, 20(06): 533-539.
[2]	YUE Jingjing, SONG Qi, JIANG Xufeng, WANG Li, ZHAO Weili, YAN Fuhua. Comparison of magnetic resonance whole body diffusion weighted imaging with FS-T2WI and FDG-PET/CT for initial staging and detection of lesion in newly diagnosed lymphoma [J]. Journal of Diagnostics Concepts & Practice, 2021, 20(06): 540-546.
[3]	GAO Yanting, ZHAO Jinyan, WANG Juan, LI Jia, XU Wen, LI Li, LIN Lihui. Analysis of bone marrow lymphocyte subsets in patients with acute myeloid leukemia and its clinical significance [J]. Journal of Diagnostics Concepts & Practice, 2020, 19(04): 407-413.
[4]	. [J]. Journal of Diagnostics Concepts & Practice, 2020, 19(04): 434-437.
[5]	MENG Leijun, ZHANG Jing, WANG Xueli, LI Zhi, ZHANG Hong, ZENG Naiyan. Identification of differentially expressed target genes in pediatric Burkitt lymphoma and its clinical application [J]. Journal of Diagnostics Concepts & Practice, 2020, 19(03): 248-257.
[6]	CHANG Rui, YANG Yanzhao, KONG Deyan, XU Jiaxu, CAO Qiqi, YANG Wenjie, YAN Fuhua, DONG Haipeng. Application of different tube voltage-current protocol in combination with KARL iterative reconstruction in CT chest scanning for novel coronavirus pneumonia screening [J]. Journal of Diagnostics Concepts & Practice, 2020, 19(02): 182-187.
[7]	YE Chenglin, YAO Yonghua, CHEN Zhen, JIA Lin. Application of plastic-embedded bone marrow biopsy in diagnosing myelodysplastic syndrome with thrombocytopenia [J]. Journal of Diagnostics Concepts & Practice, 2020, 19(02): 177-181.
[8]	PENG Zhenping, XIANG Xixi, ZHANG Sujiang, LI Jiaming. Chronic neutrophilic leukemia with leukemia-like reaction as the first-onset manifestation: a report of 2 cases and literature review [J]. Journal of Diagnostics Concepts & Practice, 2020, 19(02): 122-128.
[9]	XIAO Chao, TAO Ying, SONG Luxi, ZHAO Youshan, WU Lingyun, CHANG Chunkang. Clinical analysis of 88 patients with myeloproliferative neoplasm [J]. Journal of Diagnostics Concepts & Practice, 2020, 19(02): 115-121.
[10]	. [J]. Journal of Diagnostics Concepts & Practice, 2020, 19(02): 111-114.
[11]	. [J]. Journal of Diagnostics Concepts & Practice, 2020, 19(02): 104-110.
[12]	. [J]. Journal of Diagnostics Concepts & Practice, 2020, 19(02): 101-103.
[13]	LI Qinqin, JIN Xiaolong, YUAN Fei. Clinical and pathological analysis of systemic Epstein-Barr virus positive T-cell lymphoma of childhood:A case report and literature review [J]. Journal of Diagnostics Concepts & Practice, 2020, 19(1): 63-68.
[14]	. [J]. Journal of Diagnostics Concepts & Practice, 2019, 18(06): 692-697.
[15]	LU Hongyu, CAO Yafeng, GU Jun, WANG Jing, CHEN Mei, SONG Luxi. Diagnostic value of nerve electrophysiological studies for Bortezomib-induced peripheral neuropathy in multiple myeloma patients [J]. Journal of Diagnostics Concepts & Practice, 2019, 18(06): 640-644.